Figure 5From: Presence of HER4 associates with increased sensitivity to Herceptin™ in patients with metastatic breast cancerKaplan-Meier curve of p27Kip1 and HER2pY1248 in Herceptin™-treated breast cancer patients. (a) Dichotomised p27Kip1 immunohistochemistry (P = 0.012) and (b) phosphorylated HER2 receptor immunohistochemistry (P = 0.016). HER = human epidermal growth factor receptor.Back to article page